| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.35 | 4e-18 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |